Home R&D Page 2

R&D

Roche & Blueprint to bring new treatment to RET-altered cancer patients
Featured

Roche & Blueprint to bring new treatment to RET-altered cancer patients

Dominic Cuthbert -
0
UK researchers use llama antibodies to neutralise COVID-19 virus
Featured

UK researchers use llama antibodies to neutralise COVID-19 virus

Dominic Cuthbert -
0
US Department of Defence throws weight behind industry collaboration to evaluate COVID-19 product
Featured

US Department of Defence throws weight behind industry collaboration to evaluate COVID-19 product

Dominic Cuthbert -
0
Kymera and Sanofi to advance novel protein degrader therapies
Featured

Kymera and Sanofi to advance novel protein degrader therapies

Dominic Cuthbert -
0
Celltrion launches human clinical trial of potential COVID-19 antiviral antibody treatment
Featured

Celltrion launches human clinical trial of potential COVID-19 antiviral antibody treatment

Dominic Cuthbert -
0
Orchard licenses stable cell line tech from GSK
Featured

Orchard licenses stable cell line tech from GSK

Dominic Cuthbert -
0
Ovid Therapeutics & Angelini Pharma enter exclusive license agreement for Angelman Syndrome treatment in Europe
Featured

Ovid Therapeutics & Angelini Pharma enter exclusive license agreement for Angelman Syndrome treatment in Europe

Dominic Cuthbert -
0
GSK & Medicago to develop novel adjuvanted COVID-19 candidate vaccine
Featured

GSK & Medicago to develop novel adjuvanted COVID-19 candidate vaccine

Dominic Cuthbert -
0
Medivir & SciLifeLab collaborate on potential SARS CoV-2 inhibitors
Featured

Medivir & SciLifeLab collaborate on potential SARS CoV-2 inhibitors

Dominic Cuthbert -
0
Carmine Therapeutics & Takeda to develop novel on-viral gene therapies
Featured

Carmine Therapeutics & Takeda to develop novel on-viral gene therapies

Dominic Cuthbert -
0
123...173Page 2 of 173

© 2020 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks